KIRO Oncology
For the compounding of sterile preparations of hazardous drugs.
KIRO SP
For the compounding of sterile preparations of non-hazardous drugs.
- Visibility and greater control of accuracy via gravimetrics, barcode readers, and cameras
- Flexible design: syringes, IV bags, cassettes, and elastomeric pumps
- Enclosed, self-cleaning for staff protection
- Improved efficiency via innovative software and hardware
- EMR interface and multi-device integration
Grifols KIRO Oncology is a unique robotic system with engineering controls that focus on precision, flexibility, reliability, and safety throughout the highly complex process of compounding chemotherapy medications.
Benefits of Grifols KIRO Oncology
Patient Safety
- Precision scales perform gravimetric verification at all stages of the compounding process for assurance of dose accuracy
- In-process barcode readers and cameras capture data on drugs, disposables, and final containers with or without barcodes for accurate traceability
- Accuracy is calculated for automatic error rejection and reporting
- Beyond use dates (BUDs) are automatically calculated and tracked for final products and multi-dose vials to ensure maximum fluid removal, automatic disposal, and waste minimization
Staff Protection
- Self-cleaning process mitigates exposure to hazardous drugs and chemicals
- The cabinet is only opened for loading and unloading, protecting operators from repetitive stress injuries and exposure to hazardous drugs
- Automated compounding and self-cleaning occur in a completely enclosed environment offering unparalleled protection for staff
Regulatory Compliance
- ISO 5 compounding area meets USP <797> standards and relevant Good Manufacturing Processes (GMPs) for patient safety
- Designed to meet <USP 800> standards for operator and environment protection from unintended exposure to hazardous drugs during loading and unloading.
- Searchable, reportable database automatically captures valuable data
Efficiency
- Two robotic arms enable vial reconstitution and bag filling in parallel
- High-precision drug and diluent pumps maximize reliability of dosing success
- Accommodation of a variety of sizes and manufacturers' bags, syringes, infusers, and cassettes—as well as industry-standard disposables—mitigates disruption to current contracts and preferences
- Prepares patient-specific doses and small batches using liquid and lyophilized drugs
- Partially used vials are held within the cabinet and can be automatically used for subsequent dose preparation
- Partial-vial labels, database tracking, and intelligent alerts maximize reuse of unloaded partial vials
- Design optimizes workflow efficiencies and minimizes risks of repetitive task injuries
- Integrated system for secure disposal of hazardous waste without compromising the cabinet or cleanroom environment
Ease
- Interface engine supports bidirectional messaging with many protocols, including HL7
- Size—equivalent to a 6-foot vertical flow cabinet—facilitates integration into existing cleanroom facilities
KIRO SP is a KIRO Oncology robot used for the automated production of compounded sterile preparations of nonhazardous doses. It is particularly well-suited for specialized and/or complex dose preparations requiring an exceptionally high degree of accuracy.
Benefits of Grifols KIRO SP
Patient Safety
- Barcode scanning for reduced risk of human error
- A linear camera for visual control of labels
- Batch and expiration date control for safety
- Double gravimetric control helps to ensure accuracy
- Reports on database records
Staff Safety
- Compounding in an enclosed environment
- Self-cleaning
- Automated waste disposal
Operational Benefits
- Manages partially used vials
- Accommodates various sizes and manufacturers of vials and syringes
- Two coordinated robotic arms for higher speed during complex preparations
- Two peristaltic pumps enable fast, accurate dosing of diluents
- Robust and intuitive user interface
- Order selection (manual or automated)
- Patient-specific (patient view)
- Standard dose (product view)
- Label printing with customizable templates
- Partial vial management (internal and external)
- Media fill cycles
- Self-cleaning
- Vision system
- Technical assistance
Gri-fill 3.0 Sterile CompoundingSystem and Gri-bag
Advance patient safety and mitigate repetitive stress injuries with precision and sterility assurance.
Gri-fill® 3.0
- Prepares batches and patient-specific doses
- Accommodates syringes, IV bags, vials, bottles, cassettes, and infusers
- Precise dosing with volumetric pump
- Compact footprint
Gri-Bag
- Sterile, disposable bags in multiple sizes
- Sterilizing filter and integrity test for confirmation of sterility integral to each bag
Gri-fill 3.0 is designed to advance efficiencies and quality during the compounding of any type of intravenous mixture (including chemotherapy).
Gri-fill 3.0 is compact, easy to install, and easily adaptable to the workflow of intravenous mixtures compounding.
Benefits of Gri-fill 3.0
Patient Safety
- Sterility assurance using Gri-Bag®
- Precise dosing with volumetric pump
- Reduced risk of microbial contamination
- Lot traceability and expiration control
- In-process checks and validation
User Safety
- Avoids repetitive strain injuries
- Reduced risk of occupational exposure
- Needle-free
Efficient, Flexible, and Easy to Use
- Automatic filling and drug reconstitution
- Fits comfortably inside a standard laminar airflow hood or biosafety cabinet, without hindering its proper functioning
- Simple connection to sets and containers
- Easy to clean
- Adaptable to different source solution containers (vials, bags, bottles) and to different final containers (Gri-Bag, bags, syringes, elastomeric pumps, cassettes, etc.)
Gri-Bag
The Gri-fill system, when used in conjunction with Gri-Bag, passes each drug dose through a 0.2 μm filter incorporated in the bag and performs an integrity test on each unit after dosing. Thus, Gri-fill ensures that sterility is maintained throughout the compounding process.
Grifols is committed to providing you with the solutions you need. Please contact us for more information.